Product Detail

Name: Semaglutide  

Feature: 

It is a long-acting dosage form developed based on the basic structure of Lilalutide, and has better effect in treating type 2 diabetes.

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting glucagon like peptide 1 (GLP-1) analog, an activator of GLP-1 receptor, and has potential therapeutic effect on type 2 diabetes (T2DM).

Composition:

Assay: 99%

Appearance: White powder

CAS No. 910463-68-2

Packing: 25kg

Shelf Life: 2 years

Storage: Store in cool and dry area

Certification:ISO.